Acorda Therapeutics Inc EV/EBITDA
What is the EV/EBITDA of Acorda Therapeutics Inc?
The EV/EBITDA of Acorda Therapeutics Inc is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on NASDAQ compared to Acorda Therapeutics Inc
What does Acorda Therapeutics Inc do?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Companies with ev/ebitda similar to Acorda Therapeutics Inc
- Jia Yao has EV/EBITDA of N/A
- CLS USA has EV/EBITDA of N/A
- Overseas Chinese Town (Asia) has EV/EBITDA of N/A
- Starr Peak Exploration has EV/EBITDA of N/A
- Good Friend International has EV/EBITDA of N/A
- DoorDash Inc has EV/EBITDA of N/A
- Acorda Therapeutics Inc has EV/EBITDA of N/A
- Inspur International has EV/EBITDA of N/A
- Setubandhan Infrastructure has EV/EBITDA of N/A
- Avalon Works has EV/EBITDA of N/A
- Galileo Mining Ltd has EV/EBITDA of N/A
- Trine Acquisition has EV/EBITDA of N/A
- Dreadnought Resour has EV/EBITDA of N/A